TLRY vs. ACB, CGC, CRON, OGI, SNDL, IBRX, APLS, XENE, NAMS, and BHC
Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), ImmunityBio (IBRX), Apellis Pharmaceuticals (APLS), Xenon Pharmaceuticals (XENE), NewAmsterdam Pharma (NAMS), and Bausch Health Cos (BHC). These companies are all part of the "pharmaceutical products" industry.
Tilray Brands vs. Its Competitors
Aurora Cannabis (NASDAQ:ACB) and Tilray Brands (NASDAQ:TLRY) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.
In the previous week, Tilray Brands had 10 more articles in the media than Aurora Cannabis. MarketBeat recorded 13 mentions for Tilray Brands and 3 mentions for Aurora Cannabis. Tilray Brands' average media sentiment score of 0.46 beat Aurora Cannabis' score of 0.08 indicating that Tilray Brands is being referred to more favorably in the news media.
47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 9.4% of Tilray Brands shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by insiders. Comparatively, 0.6% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Tilray Brands has a consensus price target of $1.92, suggesting a potential upside of 172.72%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Aurora Cannabis.
Aurora Cannabis has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.
Aurora Cannabis has a net margin of 1.32% compared to Tilray Brands' net margin of -113.85%. Aurora Cannabis' return on equity of 0.13% beat Tilray Brands' return on equity.
Aurora Cannabis has a beta of 1.75, meaning that its stock price is 75% more volatile than the S&P 500. Comparatively, Tilray Brands has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500.
Summary
Aurora Cannabis beats Tilray Brands on 10 of the 16 factors compared between the two stocks.
Get Tilray Brands News Delivered to You Automatically
Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Tilray Brands Competitors List
Related Companies and Tools
This page (NASDAQ:TLRY) was last updated on 7/24/2025 by MarketBeat.com Staff